•  
  •  
 

Authors

Abstract

Background: Although observational studies show a positive association between alkaline phosphatase (ALP) levels and mortality, a causal study is not yet available.

Objective: We conducted a retrospective cohort study and a systematic one-sample Mendelian randomization (MR) study to investigate the causality of ALP on natural-cause mortality.

Methods: The study used a hospital-based cohort of Asian patients recruited from the China Medical University Hospital (CMUH) and a community-based cohort of white European participants from the UK Biobank (UKB). Two retrospective cohorts included 43,994 patients from CMUH and 80,941 participants from UKB, all aged 50–55 years, with ALP measurements. For the MR analysis, the study included 114,692 patients from CMUH and 436,583 participants from UKB, with both ALP measurements and genetic data. Natural-cause mortality excluded deaths from suicide, homicide, or accidents.

Results: Compared with patients with normal ALP levels, those with high ALP levels had a significantly increased risk of natural-cause mortality in both the CMUH (adjusted hazard ratio [aHR], 3.43; 95% confidence interval [CI], 2.98–3.95) and UKB (aHR, 2.08; 95% CI, 1.85–2.34) cohorts. A significant dose-response relationship was observed. However, the MR analysis did not provide evidence for causality between elevated ALP levels and natural-cause mortality in either the CMUH or UKB cohorts.

Conclusions: Our study reinforced a dose-dependent relationship between total ALP levels and natural-cause mortality across ancestries. However, MR analyses in both Asian and European populations did not support a causal role of total ALP. Future research should focus on verifying whether these findings are consistent for specific ALP isoforms and disease outcomes.

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS